{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T18:18:14Z","timestamp":1783448294916,"version":"3.55.0"},"reference-count":13,"publisher":"Walter de Gruyter GmbH","issue":"2","license":[{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Mucpharm Pty Ltd., Australia"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_pp-2025-0044_abs_001\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>\n                      Pseudomyxoma peritonei (PMP) is a rare peritoneal malignancy characterised by progressive accumulation of mucin within the abdomen. The gold standard of PMP treatment is cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC). BromAc\n                      <jats:sup>\u00ae<\/jats:sup>\n                      is a mucolytic therapy developed for patients with inoperable PMP but its efficacy is reduced with hard mucin. Shear wave elastography (SWE) is an ultrasound technique that quantifies the mechanical and elastic properties of tissues. It was hypothesised that SWE could provide a preoperative, objective assessment of mucin consistency.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_pp-2025-0044_abs_002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective pilot study of patients with PMP who underwent SWE prior to CRS-HIPEC was conducted. All patients underwent elastography at a specialised radiology practice. SWE results across the four quadrants of the abdomen were compared with intraoperative assessment of mucin consistency.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_pp-2025-0044_abs_003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The study yielded 12 eligible patients between Jan 2020 to Apr 2025. The mean SWE value for hard mucin was 5.9\u202fkPa compared with 4.5\u202fkPa for soft. This difference was not statistically significant (p=0.64).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_pp-2025-0044_abs_004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>There is a clinical need for an objective assessment of mucin consistency in patients with PMP. While limited by its small sample size, this study found that the mean SWE result for hard mucin was slightly higher than for\u00a0soft.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/pp-2025-0044","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T22:08:27Z","timestamp":1778278107000},"page":"83-87","source":"Crossref","is-referenced-by-count":0,"title":["Shear wave elastography to distinguish between hard and soft mucin in pseudomyxoma peritonei"],"prefix":"10.1515","volume":"11","author":[{"given":"Carissa","family":"Vici","sequence":"first","affiliation":[{"name":"Peritonectomy Unit, St George Hospital, South Eastern Sydney Local Health District , Kogarah , NSW , Australia"},{"name":"University of New South Wales Saint George and Sutherland Clinical Campuses , Kogarah , NSW , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nishka","family":"Tapaswi","sequence":"additional","affiliation":[{"name":"Peritonectomy Unit, St George Hospital, South Eastern Sydney Local Health District , Kogarah , NSW , Australia"},{"name":"University of New South Wales Saint George and Sutherland Clinical Campuses , Kogarah , NSW , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"Vaska","sequence":"additional","affiliation":[{"name":"Peritonectomy Unit, St George Hospital, South Eastern Sydney Local Health District , Kogarah , NSW , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Morris","sequence":"additional","affiliation":[{"name":"Peritonectomy Unit, St George Hospital, South Eastern Sydney Local Health District , Kogarah , NSW , Australia"},{"name":"University of New South Wales Saint George and Sutherland Clinical Campuses , Kogarah , NSW , Australia"},{"name":"Mucpharm Pty. Ltd. , Kogarah , NSW , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2026,5,8]]},"reference":[{"key":"2026070717563295793_j_pp-2025-0044_ref_001","doi-asserted-by":"crossref","unstructured":"Pillai, K, Akhter, J, Mekkawy, A, Chua, TC, Morris, DL. Physical and chemical characteristics of mucin secreted by pseudomyxoma peritonei (PMP). Int J Med Sci 2017;14:18\u201328. https:\/\/doi.org\/10.7150\/ijms.16422.","DOI":"10.7150\/ijms.16422"},{"key":"2026070717563295793_j_pp-2025-0044_ref_002","doi-asserted-by":"crossref","unstructured":"Yang, J, Glenn, D, Lodh, S, Valle, S, Morris, DL. Long-term treatment of unresectable pseudomyxoma peritonei with multiple treatments of intratumoural bromelain and acetylcysteine (BromAc\u00ae): a case report. Case Rep Oncol 2023;16:1551\u20136. https:\/\/doi.org\/10.1159\/000534202.","DOI":"10.1159\/000534202"},{"key":"2026070717563295793_j_pp-2025-0044_ref_003","doi-asserted-by":"crossref","unstructured":"Lin, YL, Xu, DZ, Li, XB, Yan, FC, Xu, HB, Peng, Z, et al.. Consensuses and controversies on pseudomyxoma peritonei: a review of the published consensus statements and guidelines. Orphanet J Rare Dis 2021;16:85. https:\/\/doi.org\/10.1186\/s13023-021-01723-6.","DOI":"10.1186\/s13023-021-01723-6"},{"key":"2026070717563295793_j_pp-2025-0044_ref_005","doi-asserted-by":"crossref","unstructured":"Valle, SJ, Akhter, J, Mekkawy, AH, Lodh, S, Pillai, K, Badar, S, et al.. A novel treatment of bromelain and acetylcysteine (BromAc) in patients with peritoneal mucinous tumours: a phase I first in man study. Eur J Surg Oncol 2021;47:115\u201322. https:\/\/doi.org\/10.1016\/j.ejso.2019.10.033.","DOI":"10.1016\/j.ejso.2019.10.033"},{"key":"2026070717563295793_j_pp-2025-0044_ref_006","unstructured":"Wen, HK, Valle, SJ, Morris, DL. Bromelain and acetylcysteine (BromAc\u00ae): a novel approach to the treatment of mucinous tumours. Am J Cancer Res 2023;13:1522\u201332."},{"key":"2026070717563295793_j_pp-2025-0044_ref_007","doi-asserted-by":"crossref","unstructured":"Villarejo-Campos, P, Garc\u00eda-Arranz, M, Qian, S, Jim\u00e9nez de los Galanes, S, Dom\u00ednguez-Prieto, V, V\u00e9lez-Pinto, JF, et al.. Under the hood: understanding the features of mucin in pseudomyxoma peritonei. J\u00a0Clin Med 2023;12:4007. https:\/\/doi.org\/10.3390\/jcm12124007.","DOI":"10.3390\/jcm12124007"},{"key":"2026070717563295793_j_pp-2025-0044_ref_004","doi-asserted-by":"crossref","unstructured":"Taljanovic, MS, Gimber, LH, Becker, GW, Latt, LD, Klauser, AS, Melville, DM, et al.. Shear-wave elastography: basic physics and musculoskeletal applications. Radiographics 2017;37:855\u201370. https:\/\/doi.org\/10.1148\/rg.2017160116.","DOI":"10.1148\/rg.2017160116"},{"key":"2026070717563295793_j_pp-2025-0044_ref_008","unstructured":"National Health and Medical Research Council, Australian Research Council and Universities Australia. National statement on ethical conduct in human research. Canberra: National Health and Medical Research Council; 2023."},{"key":"2026070717563295793_j_pp-2025-0044_ref_009","doi-asserted-by":"crossref","unstructured":"Lohani, K, Shetty, S, Sharma, P, Govindarajan, V, Thomas, P, Loggie, B. Pseudomyxoma peritonei: inflammatory responses in the peritoneal microenvironment. Ann Surg Oncol 2014;21:1441\u20137. https:\/\/doi.org\/10.1245\/s10434-013-3261-6.","DOI":"10.1245\/s10434-013-3261-6"},{"key":"2026070717563295793_j_pp-2025-0044_ref_010","doi-asserted-by":"crossref","unstructured":"Mori, Y, Dendl, K, Cardinale, J, Kratochwil, C, Giesel, FL, Haberkorn, U. FAPI PET: fibroblast activation protein inhibitor use in oncologic and nononcologic disease. Radiology 2023;306:e220749. https:\/\/doi.org\/10.1148\/radiol.220749.","DOI":"10.1148\/radiol.220749"},{"key":"2026070717563295793_j_pp-2025-0044_ref_011","doi-asserted-by":"crossref","unstructured":"Zhao, Q, Wei, T, Ma, R, Fu, Y, Yang, R, Su, Y, et al.. Progress on immuno-microenvironment and immune-related therapies in patients with pseudomyxoma peritonei. Cancer Biol Med 2024;21:586\u2013605. https:\/\/doi.org\/10.20892\/j.issn.2095-3941.2024.0109.","DOI":"10.20892\/j.issn.2095-3941.2024.0109"},{"key":"2026070717563295793_j_pp-2025-0044_ref_012","doi-asserted-by":"crossref","unstructured":"Udovicich, C, Perera, M, Hofman, MS, Siva, S. FAPI PET\/CT: a new kid on the block for RCC. Eur J Nucl Med Mol Imag 2024;51:862\u20133. https:\/\/doi.org\/10.1007\/s00259-023-06569-7.","DOI":"10.1007\/s00259-023-06569-7"},{"key":"2026070717563295793_j_pp-2025-0044_ref_013","doi-asserted-by":"crossref","unstructured":"Bai, D, Shi, G, Liang, Y, Li, F, Zheng, Z, Wang, Z. A radiomics-based interpretable model integrating delayed-phase CT and clinical features for predicting the pathological grade of appendiceal pseudomyxoma peritonei. BMC Med Imag 2025;25:300. https:\/\/doi.org\/10.1186\/s12880-025-01843-6.","DOI":"10.1186\/s12880-025-01843-6"}],"container-title":["Pleura and Peritoneum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/pp-2025-0044\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/pp-2025-0044\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T17:57:16Z","timestamp":1783447036000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/pp-2025-0044\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,8]]},"references-count":13,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,5,8]]},"published-print":{"date-parts":[[2026,7,6]]}},"alternative-id":["10.1515\/pp-2025-0044"],"URL":"https:\/\/doi.org\/10.1515\/pp-2025-0044","relation":{},"ISSN":["2364-7671","2364-768X"],"issn-type":[{"value":"2364-7671","type":"print"},{"value":"2364-768X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,8]]}}}